INTERCEPT PHARMACEUTICALS INC | 2013 | FY | 3


The Company’s activity related to warrants to purchase shares of common stock of the Company is noted in the table below.

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Warrants to Purchase Common Stock

 

Weighted Average
Exercise Price

 

Expiration

Warrants issued in 2003

 

 

2,163

 

 

$

2.89

 

 

 

(1)

 

Warrants issued in 2003

 

 

2,163

 

 

 

8.67

 

 

 

(1)

 

Warrants issued in 2004

 

 

117,642

 

 

 

2.89

 

 

 

(2)

 

Warrants issued in 2004

 

 

19,609

 

 

 

2.89

 

 

 

(1)

 

Warrants issued in 2004

 

 

117,640

 

 

 

8.67

 

 

 

(2)

 

Warrants issued in 2005

 

 

138,461

 

 

 

7.22

 

 

 

(2)

 

Warrants issued in 2006

 

 

86,538

 

 

 

9.82

 

 

 

(3)

 

Warrants issued in 2006

 

 

20,481

 

 

 

9.82

 

 

 

(3)

 

Warrants exercised in 2007

 

 

(51,922

)   

 

 

7.22

 

 

Warrants issued in 2008

 

 

108,169

 

 

 

10.40

 

 

 

(2)

 

Warrants issued in 2010

 

 

865,381

 

 

 

10.40

 

 

 

1/25/2015

 

Warrants expired in 2010

 

 

(86,539

)   

 

 

7.22

 

 

 

 

 

Warrants expired in 2011

 

 

(107,019

)   

 

 

9.82

 

 

 

 

 

Warrants issued and outstanding as of December 31, 2011

 

 

1,232,767

 

 

 

9.38

 

 

 

 

 

Warrants exercised in 2012

 

 

(70,802

)   

 

 

8.59

 

 

 

 

 

Warrants issued and outstanding as of December 31, 2012

 

 

1,161,965

 

 

$

9.43

 

 

 

 

 

Warrants exercised in 2013

 

 

(287,709

)

 

 

6.62

 

 

 

 

 

Warrants expired in 2013

 

 

(8,875

)

 

 

5.77

 

 

 

 

 

Warrants issued and outstanding as of December 31, 2013

 

 

865,381

 

 

$

10.40

 

 

 

 

 

 

________________________

1.

All exercised.

2.

All exercised or expired. 

3.

All expired.


us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock